RxDoctor Payments Data

Rick Kenney, DO

Internal Medicine · Newport Beach, CANPI 1487699641

Payments from drug & device makers

$311in general payments, 2019–2025

Across 27 payments — averaging $11.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$158
  • Merck$47
  • Boston Scientific$37
  • Johnson & Johnson$26
  • Zimmer Biomet$22
  • Eisai Inc.$21

What the payments were for

  • Food & beverage$311100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer19$158
Merck3$47
Boston Scientific1$37
Johnson & Johnson2$26
Zimmer Biomet1$22
Eisai Inc.1$21

How this compares

$311 in reported general payments places this provider in the 60th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$227,901
Medicare patients
404
Services billed
2,690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$85,173
EliquisApixaban66$51,093
MounjaroTirzepatide40$39,939
AmbienZolpidem Tartrate12$11,385
NuedextaDextromethorphan Hbr/Quinidine14$10,938
PremarinEstrogens, Conjugated21$8,819
Sucralfate18$5,578
SynthroidLevothyroxine Sodium58$3,955
Levothyroxine Sodium282$2,421
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen116$2,210
Losartan Potassium255$2,142
Gabapentin140$2,140
Rosuvastatin Calcium207$2,118
Nebivolol Hcl14$2,024
Ezetimibe69$1,712

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$158$59,91287 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 13,581 internal medicine providers in California.

Other internal medicine in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →